A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)

Summary

The purpose of this study is to test the safety and effectiveness of MK-6213 as compared to MK-6213/Atorvastatin in participants 18 to 75 years) with high cholesterol.

Timeline

Start

2008-06-14

Primary completion

2009-01-08

Completion

2009-01-08

Outcome

Met primary endpoint

registry MK-6213 160 mg + Atorvastatin 20 mg vs Atorvastatin 20 mg; Difference in Percentage Change -10.0 (95% CI -14.6 to -5.5) NCT00687271 ↗

Drugs

Indications